NYVAC-HIV-PT4 vaccine

BIOLOGICAL2 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID)

Conditions

HIV Infections

Phase 1

Evaluating the Safety and Immune Response to Three HIV Vaccine Schedules in Healthy, HIV-Uninfected Adults

CompletedNCT01783977

National Institute of Allergy and Infectious Diseases (NIAID)HIV Infections

Start: 2013-04-30End: 2018-10-24Updated: 2021-10-15

Evaluating the Safety and Immune Response to Two HIV Vaccine Regimens in Healthy, HIV-Uninfected Adults in the United States and South Africa

WithdrawnNCT01927835

National Institute of Allergy and Infectious Diseases (NIAID)HIV Infections

Updated: 2021-10-15